The global vaccine industry is undergoing a paradigm shift, driven by biotechnological breakthroughs and an increasing emphasis on preventive veterinary medicine. As the world faces emerging zoonotic threats, the demand for high-purity, inactivated, and live attenuated vaccines has surged by over 15% annually in emerging markets. Industrial-scale production now requires more than just biological efficacy; it demands rigorous stability, cold-chain compatibility, and cost-effectiveness for mass distribution.
In the industrial landscape, automation and AI are becoming the backbone of vaccine formulation. Digital twins are used to simulate fermentation processes, while automated inspection lines ensure 100% vial integrity. For global enterprises, sourcing from a reliable China Best Vaccine Products Factory means accessing a supply chain that combines massive scale with meticulous GMP compliance.
Our facilities are fully GMP and ISO certified, ensuring every batch meets international safety standards for global export.
Collaboration with top-tier research institutes allows us to offer custom strains and advanced bivalent formulations.
From vaccine blending to high-speed inspection lines, we provide turnkey solutions for pharmaceutical production.
Hangzhou Jeci Biochem Technology Co., Ltd. stands at the intersection of traditional pharmaceutical expertise and modern biotechnology. In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Understanding local environmental stressors is crucial for vaccine efficacy. Whether it is the humid climates of Southeast Asia or the large-scale cattle ranches in South America, our products are engineered for diverse localized application scenarios. We provide not only the vaccine but also the Production Equipment necessary for localized processing.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. Our CE-approved blending vessels and inspection lines are designed to minimize human error and maximize yield.
Drugs and intermediates are widely used in the following aspects (partial):
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
SJ medical
